Trial record 1 of 3 for:
phoenicis
Study of PTW-002 in Patients With Dominant or Recessive Dystrophic Epidermolysis Bullosa Due to Mutation(s) in Exon 73 of the COL7A1 Gene
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05529134 |
|
Recruitment Status :
Not yet recruiting
First Posted : September 6, 2022
Last Update Posted : March 31, 2023
|
Sponsor:
Phoenicis Therapeutics
Information provided by (Responsible Party):
Phoenicis Therapeutics
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Not yet recruiting |
|---|---|
| Estimated Primary Completion Date : | April 30, 2024 |
| Estimated Study Completion Date : | July 31, 2024 |